BioSpace News Archive

AVITA Medical, Inc. announced that it will report its fourth quarter and full year 2022 financial results after the close of the U.S. financial markets on Thursday, February 23, 2023.

BIOLASE, Inc., the global leader in dental lasers, announced that the Company has been awarded a Top Workplaces 2022 honor by the Inland News Group.

Addex Therapeutics announced notification from The Nasdaq Stock Market LLC that it has regained compliance with the minimum bid price requirement of $1.00 per ADS share under Nasdaq Listing Rule 5550 and currently meets all other applicable criteria for continued listing.

Roche announced that it has expanded its collaboration with Janssen Biotech Inc. to create companion diagnostics for targeted therapies, further strengthening research and innovation activities.

Ipsen, a global specialty-driven biopharmaceutical company, presents its financial results for the year and the fourth quarter of 2022.

Celyad Oncology announces the publication of the data from the haematological arm of the THINK study which evaluated CYAD-01 in relapsed or refractory acute myeloid leukaemia and myelodysplastic syndromes or multiple myeloma patients.

SeqOne announced the results of a long-standing research collaboration with Pr. Laurent Mesnard, Co-Director of the French National center for Thrombotic MicroAngiopathies, aimed at improving the diagnosis and management of patients suspected of suffering from thrombotic microangiopathies and atypical Hemolytic syndrome.

Sequana Medical NV announces its financial results for the year ended 31 December 2022, and provides a business update and outlook for 2023.

Evotec SE announced that the Company has extended and expanded its integrated multi-target drug discovery agreement with data-driven biotech creation firm, Related Sciences, to continue to grow their joint portfolio of drug development candidates through 2030, leveraging Evotec’s industry-leading capabilities across the full R&D continuum.

Lytix Biopharma AS, a Norwegian immuno-oncology company, will release its fourth quarter and second half 2022 results on Thursday, 16 February 2023 at 8am CEST.